Company intelligence / Profile preview

Fungi Perfecti

Shelton, Washington, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Fungi Perfecti is a commercial-stage mycology company. While primarily known for nutraceuticals, they have participated in NIH-funded clinical trials, notably a Phase 1 study showing that Turkey Tail (Trametes versicolor) mushroom mycelium supports the immune system in women with breast cancer after standard medical treatment.

Therapeutic areas: OncologyImmunologyNeurologyOther
Modalities: Microbial therapyNatural productsSmall moleculeBiologic
Industry: Biotech

Partnerships

Washington State UniversityNational Institutes of HealthUnited States Department of Defense

Beyond the preview

Go deeper on Fungi Perfecti.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungi Perfecti.

Explore the full profile